Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes

Clinical trial NCT00605475 · COMPLETED

Trial details

NCT number: NCT00605475
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2007-12-01
Primary completion: 2010-09-01
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.